$10.75
5.65% today
Nasdaq, Nov 11, 05:50 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$10.17
+0.43 4.41% 1M
+1.21 13.50% 6M
-2.28 18.31% YTD
-2.92 22.31% 1Y
-1.17 10.32% 3Y
-5.47 34.97% 5Y
-35.27 77.62% 10Y
-9.92 49.38% 20Y
Nasdaq, Closing price Mon, Nov 10 2025
+0.05 0.49%

New AI Insights on Viatris Insights AI Insights on Viatris

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$11.7b
Enterprise Value
$23.8b
Net debt
$12.1b
Cash
$666.2m
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
negative | 4.4
P/S
0.8 | 0.8
EV/Sales
1.7 | 1.7
EV/FCF
14.0
P/B
0.8
Dividends
DPS
$0.48
Yield 1Y | 5Y
4.7% | 3.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
-90.6% | 117.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$14.1b | $14.2b
EBITDA
$4.2b | $4.2b
EBIT
$1.4b | $3.8b
Net Income
$-3.5b | $2.7b
Free Cash Flow
$1.7b
Growth (TTM | estimate)
Revenue
-7.4% | -3.6%
EBITDA
-0.4% | -10.9%
EBIT
1.9% | 113.7%
Net Income
-436.5% | 528.6%
Free Cash Flow
-9.4%
Margin (TTM | estimate)
Gross
40.2%
EBITDA
29.7% | 29.3%
EBIT
10.1%
Net
-24.6% | 19.1%
Free Cash Flow
12.1%
Financial Health
Equity Ratio
44.9%
Return on Equity
-3.4%
ROCE
4.6%
ROIC
4.0%
Debt/Equity
0.8
More
EPS
$-3.0
FCF per Share
$1.5
Short interest
2.9%
Employees
32k
Rev per Employee
$460.0k
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Viatris forecast:

8x Buy
50%
6x Hold
38%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Viatris forecast:

Buy
50%
Hold
38%
Sell
13%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14,116 14,116
7% 7%
100%
- Direct Costs 8,448 8,448
3% 3%
60%
5,668 5,668
13% 13%
40%
- Selling and Administrative Expenses 3,399 3,399
21% 21%
24%
- Research and Development Expense 838 838
3% 3%
6%
4,189 4,189
0% 0%
30%
- Depreciation and Amortization 2,759 2,759
2% 2%
20%
EBIT (Operating Income) EBIT 1,430 1,430
2% 2%
10%
Net Profit -3,468 -3,468
436% 436%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
Seeking Alpha
15 minutes ago
Viatris Inc. ( VTRS ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Theodora Mistras - Chief Financial Officer Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division Good day, everybody. My name is Ash Verma, I cover SMID-cap, biotech and spec pharma.
Neutral
Seeking Alpha
5 days ago
Viatris Inc. ( VTRS ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants William Szablewski Scott Smith - CEO & Director Philippe Martin - Chief R&D Officer Corinne Le Goff - Chief Commercial Officer Theodora Mistras - Chief Financial Officer Conference Call Participants Leszek Sulewski - Truist Securities, Inc., Research Division Matthew Dellatorre - Goldman Sachs Group, I...
Positive
Reuters
5 days ago
Drugmaker Viatris beat third-quarter estimates for profit and revenue on Thursday, driven by strong demand for its branded drugs in China and emerging markets.
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 32,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today